The Brain-Heart Continuum Episode 3 – Real-World Evidence on Healthcare Utilization

Join Jacob Abraham, MD, and Philip Adamson, MD, as they discuss newly released data published in the Journal of Cardiac Failure and presented at THT 2025. Dr. Abraham shares his perspective on the retrospective analysis of the real-world all-payer data which demonstrated the significant clinical impact of Barostim in reducing hospitalizations and emergency department visits. Dr. Abraham is the Section Head of Advanced Heart Failure at Providence St. Vincent Medical Center in Portland, Ore.

This podcast represents the views of our guest speaker and Dr. Philip Adamson’s personal views as a physician/scientist and does not necessarily represent the views of CVRx. Dr. Abraham is a paid consultant of CVRx. Please also note that the study discussed in this podcast (available in The Journal of Cardiac Failure) was funded by CVRx and its authors were either consultants or employees of CVRx, as disclosed in the manuscript. For more information regarding Barostim therapy, featured during this podcast, please refer to the approved indication, important safety information and instructions for use. For more educational content please visit CVRx.com. Copyright 2025 CVRx, Inc. All rights reserved. PRO-1032-US-ENG-v1 (v1.0)